Skip to main content

Magna Announces Third Quarter 2025 Results

Strong execution and operational excellence drove improved performance Year-over-year comparison (third quarter of 2025 versus third quarter of 2024):Sales increased 2% to $10.5 billion, supported by a 3% rise in global light vehicle production Income from operations before income taxes was $473 million, down 32%, as the prior year included recognition of Fisker deferred revenue as Other income Adjusted EBIT increased 3% to $613 million, with a 10 basis-point improvement in Adjusted EBIT margin Diluted earnings per share were $1.08; Adjusted diluted earnings per share rose 4% to $1.33Increase 2025 outlook for Sales, Adjusted EBIT Margin, and Adjusted Net Income attributable to Magna, reflecting confidence in our strategic positioning and execution Board approved Normal Course Issuer Bid to purchase up to 10% of our public float...

Continue reading

Facephi Reports Solid 1H25 Results, Expects Strong Acceleration in 2H25, and Provides 2025–2026 Financial Guidance

Facephi Reports Solid 1H25 Results, Expects Strong Acceleration in 2H25, and Provides 2025–2026 Financial GuidancePositive Free Cash Flow (+€0,01 mm) over the last 12 months in terms of constant currency (CC); representing an unprecedented milestone in the Company’s history. EBITDA near break-even, with a result of -€0,2 mm or +€0,1 mm in CC; showing a significant improvement compared to -€2,7 mm in H1 2024. Financial Projections 2025–2026: Revenue and EBITDA are expected to grow by +26% and +232% CAGR 2024–2026, respectively, with an estimated Free Cash Flow/EBITDA ratio of 39% for 2026.Alicante, October 30, 2025 – Facephi Biometría, SA (BME Growth: FACE; Euronext Growth Paris: ALPHI) (“Facephi” or the “Company”), a global leader in AI/ML-powered digital identity verification and anti-fraud protection solutions, today released...

Continue reading

DXS International plc ((AQSE: DXSP) – Final Results

DXS INTERNATIONAL PLC (AQSE: DXSP) ANNUAL RESULTS for the year ended 30 April 2025 The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce its audited Final Results for the year ended 30 April 2025. Financial highlights:Revenue increased by 5% to £3,469,917 (2024: £3,308,359). Core recurring revenue model remains resilient. Available cash at the period end was £428,957 plus unutilised debtor drawdowns of £245,043 (2024 £469,617). Loss for the year of £94,750 (2024: Loss of £4,738,686: a combination of increased amortisation of £1,020,916 and impairment of £4,378,114). The R&D tax credits were down – from £212,964 – 2024 to £80,398 -2025 – due to HMRC’s new restrictions for companies...

Continue reading

Digitalist Group Plc’s Business Review, 1 January – 30 September 2025

Digitalist Group Plc’s Business Review, 1 January – 30 September 2025 SUMMARY  July–September 2025 (comparable figures for 2024 in parentheses): Turnover: EUR 3.3 million (EUR 3.6 million), decrease: -6.7%.  EBITDA: EUR -0.6 million (EUR -0.2 million), -18.8% of turnover (-5.0%). EBIT: EUR -0.8 million (EUR -0.3 million), -22.7% of turnover (-8.7%).  Net income: EUR -1.5 million (EUR -1.5 million), -45.7% of turnover (-40.8%). Earnings per share: EUR -0.54 (EUR -0.52).* Earnings per share (diluted): EUR -0.54 (EUR -0.52).**The information is presented after the share consolidation on 15 August, 2025. Following the combination of shares, the new total number of shares is 2,773,721.  January–September 2025 (comparable figures for 2024 in parentheses): Turnover: EUR 12.4 million (EUR 11.5 million), increase: 8.1%.  EBITDA: EUR -1.0 million...

Continue reading

Kalmar’s interim report January–September 2025: Improved profitability in the quarter

KALMAR CORPORATION, INTERIM REPORT JANUARY–SEPTEMBER 2025, 31 OCTOBER 2025 AT 9:00 AM (EET) Kalmar’s interim report January–September 2025: Improved profitability in the quarterRecord-high comparable operating profit margin of 13.8 percent, supported by Services and improved efficiency Global market uncertainty persisted, volatility in the tariff and trade policy landscape dampened decision-making Solid performance in Services with both increased orders received and profitability Equipment orders received declined from the comparison period by 20 percent, however, showing solid growth year-to-date Guidance for 2025 unchanged.July–September 2025 in brief:Orders received decreased by 10 percent and totalled EUR 375 (416) million Order book amounted to EUR 961 million (31 Dec 2024: EUR 955 million) Sales increased by 3 percent...

Continue reading

Tallinna Vesi’s third-quarter sales reached €18.2 million

The sales of AS Tallinna Vesi in the third quarter of 2025 were €18.2 million, increasing 10.8% compared to the same period last year. Revenue growth was most affected by a change in price due to the need for critical investments.  Aleksandr Timofejev, CEO of Tallinna Vesi, said that the third quarter was characterised by continued progress with planned investments and a commitment to the continuity of the vital service. “Summer is the busiest time of year for water and sewer pipeline construction projects, and our team made the most of it. Four important stormwater receiving systems have been completed or are nearing completion in various districts of Tallinn. This creates the conditions necessary for developing a stormwater network,” he said. Timofejev noted that creating modern stormwater solutions is essential for the functioning...

Continue reading

Good customer activity and strong credit quality led to solid results for the first nine months of 2025 Net profit of DKK 16.7 billion

Press releaseDanske BankBernstorffsgade 40DK-1577 København VTel. + 45 45 14 14 00 31 October 2025 Page 1 of 3Good customer activity and strong credit quality led to solid results for the first nine months of 2025 Net profit of DKK 16.7 billion Carsten Egeriis, Chief Executive Officer, comments on the financial results: “We delivered a solid financial result for the first nine months of 2025 following strong execution on strategic priorities according to our Forward ’28 strategy. Our financial performance was driven by resilient net interest income, continually strong net fee income, effective cost management and low impairments as a result of the strong credit quality of our loan portfolio. Increased customer activity, a growing corporate customer base and market share gains in the corporate segment drove growth in lending and...

Continue reading

Vistin Pharma ASA: Third quarter and YTD 2025 financial results

Vistin Pharma ASA: Third quarter and YTD 2025 financial results Oslo, Norway, 31st of October 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2025. Revenue in the third quarter ended at MNOK 109 compared to MNOK 106 in Q3 2024. The increase in revenue was driven by 10% higher sales volume. Revenue YTD 2025 ended at MNOK 342 compared to MNOK 316 YTD last year, an increase of 8% Third quarter EBITDA ended at MNOK 28 compared to MNOK 29 in Q3 2024. EBITDA of MNOK 28 positively affected by higher sales volume, offset by lower global metformin prices compared to same quarter last year. EBITDA for first three months of 2025 ended at MNOK 89 compared to MNOK 77 YTD 2024, an increase of 16%. The net profit ended at MNOK 18.5 (16.6) for the third quarter of 2025. All time high production volume in the...

Continue reading

KH Group Plc’s Business Review January–September 2025: Group net sales increased, rescue vehicles integrated into strategy

KH Group Plc Stock Exchange Release 31 October 2025 at 8:00 am EET KH Group Plc’s Business Review January–September 2025: Group net sales increased, rescue vehicles integrated into strategy This is the summary of the Business Review for January–September 2025. The full Business Review is attached to this release and is also available on the company’s website at www.khgroup.com. KH Group July–September 2025 Net sales amounted to EUR 45.3 (39.7) million. Comparable operating profit was EUR 1.2 (1.4) million. Operating profit was EUR 0.9 (1.1) million. Net profit for the period from continuing operations was EUR -0.1 (-0.2) million. Earnings per share from continuing operations were EUR -0.0 (0.0).KH Group January–September 2025 Net sales amounted to EUR 141.3 (132.3) million. Comparable operating profit was EUR 2.2 (3.8) million. Operating...

Continue reading

Quarterly information as at September 30th, 2025

Solid performance over the first nine months 2025 outlook confirmed Strong fundamentals and sustained market demandCergy, October 31st, 2025 Solid 9m 2025 revenue growth, driven by Germany and North-Western Europe  Revenue: €7,518.7m, up +5.4% year-on-year, including +3.6% growth from acquisitions and +2.2% organic growth, of which +5.0% in Germany and + 6.5% in North-Western Europe Sustained market demand, underpinned by our two powerful structural drivers: the energy transition and digital transformation Q3 2025 revenue up +4.7% including +1.8% organic growthHighly positive underlying trends in High Voltage activities, supported by strong order intake and backlog. Following exceptional growth in the first half of the year, projects in Germany and the Netherlands progressed, as planned, at a more measured pace France demonstrated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.